PharmaKB logo
Company Reports
Company Reports
Drug Reports
Drug Reports
Disease Reports
Disease Reports
Sets
Sets
Favorites
Favorites
Log in
Log in
AboutPricing
Disease ReportsNeuroblastoma
MeSH D009447 - neuroblastoma
Favorite
Competitive Landscape
Events Timeline
Commercial
Clinical Trials
Competitive landscape
See list view
D018241:Primitive neuroectodermal tumors peripheral
0 Companies
0 Drugs
Success rate
D009447: 
Neuroblastoma
54 Companies
12 Drugs
$
Success rate
D018304:Olfactory esthesioneuroblastoma
0 Companies
0 Drugs
Success rate
D018305:Ganglioneuroblastoma
0 Companies
0 Drugs
Success rate
Events Timeline
Loading
Commercial
Company Name
Drug Name
Trade Name
Patent Expires
Approval Date
Revenue
Period
TevaIsotretinoin Claravis  2003-04-11   
Doxorubicin Doxorubicin  1995-07-28   
Etoposide Etoposide  1994-02-10   
Doxorubicin Myocet (previously Myocet)  2000-07-13   
Cyclophosphamide Neosar  1993-04-29   
Etoposide Toposar  1995-02-27   
Vincristine Vincasar  1987-07-17   
Vincristine Vincristine  1999-09-01   
Cisplatin Cisplatin  2000-05-16   
Meitheal PharmaceuticalsDacarbazine Dacarbazine  1998-08-27   
Dactinomycin Dactinomycin  2020-11-13   
Melphalan Melphalan  2021-05-28   
Etoposide Etoposide  1996-07-24   
IngenusCyclophosphamide Cyclophosphamide 2036-02-15 2020-07-30   
Melphalan Melphalan  2020-02-18   
MylanIsotretinoin Amnesteem  2002-11-08   
Doxorubicin Doxorubicin  2011-10-28   
Etoposide Etoposide  2001-09-19   
Melphalan Melphalan  2009-06-09   
Cisplatin Cisplatin  2012-04-18   
RocheIsotretinoin Accutane  1982-05-07   
CiplaCyclophosphamide Cyclophosphamide  2019-01-18   
BayerDacarbazine Dtic-dome  1982-01-01   
PfizerDoxorubicin Adriamycin  1991-01-30   
Doxorubicin Doxorubicin  1982-01-01   
Eli LillyVincristine Oncovin  1982-01-01   
Dr Reddys LaboratoriesDoxorubicin Doxorubicin  2017-05-15   
Melphalan Melphalan  2017-12-08   
Isotretinoin Zenatane  2013-03-25   
Cyclophosphamide Cyclophosphamide 2035-07-13 2023-06-07   
1
2
3
4
5
6
>
Clinical Trials
Historical Success Rate
Phase 1
70%
87/124
Phase 2
27%
37/136
Phase 3
41%
25/61
Approved: 14Overall Success rate: 8%
All Clinical Trials
Therapeutic Areas:
All
Classification:
All
Approval:
All
Status:
All
Phases:
All
Company name
Phase 1
Phase 2
Phase 3
Phase 4
Drug Name
Teva
Cisplatin,
Cyclophosphamide,
Doxorubicin,
Doxorubicin hydrochloride,
Etoposide,
Vincristine,
Vincristine sulfate
Roche
Isotretinoin,
Idasanutlin
Bayer
Dacarbazine,
Sodium chloride,
Bay806946
Pfizer
Doxorubicin,
Doxorubicin hydrochloride,
Tbo-filgrastim,
Lenograstim
Eli Lilly
Vincristine,
Vincristine sulfate
Dr Reddys Laboratories
Doxorubicin,
Doxorubicin hydrochloride,
Isotretinoin
Sun Pharmaceutical Industries
Isotretinoin
1
2
3
4
>
© 2020-2023 Collaborative Drug Discovery Inc. (CDD) | Terms of Use